Genosco is a clinical stage biotech company based in Boston, specializing in the discovery and development of novel kinase inhibitors to address the unmet medical needs of patients. With an experienced team dedicated to kinase targeted therapies and a proprietary discovery platform called G-SMART, Genosco is able to identify rare sequences and rapidly generate highly selective compounds, resulting in a strong and diverse pipeline of independent and partnered programs.
Driven by a shared vision to improve patients' quality of life, Genosco focuses on strengthening their cutting-edge science-based discovery platform and fostering an open and positive working environment that encourages employees to unleash their full creativity. With a proven track record and successful out-licensing partnerships, Genosco is committed to making small innovations that lead to pronounced medical breakthroughs.
Generated from the website